Ceribell Delirium Monitor Outcomes Pilot Study
← catalyst calendarNCT07449416 · readout ≤ 73 d
Sponsored by Ceribell Inc. (industry) · CBLL — their whole pipeline →.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Non randomized · None · Screening
Enrollment
100estimated
Sites
2
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-03-15 | actual | When the study began enrolling |
| Primary completion | Oct 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2026-03-04 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-22 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Delirium in the Intensive Care Unit
Intervention
- Device: Ceribell Delirium Monitoring System
Primary outcome
what the primary-completion date above is the date OFProportion of Participants with Delirium Diagnosed Outside Routine Standard-of-Care Assessments
measured From ICU admission to ICU discharge (up to 7 days)
Permalink · CBLL's whole pipeline · Catalyst calendar · Every registered study · What changed